Skip to main content

Osteoarthritis, Hip

4
Pipeline Programs
16
Companies
32
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
2
1
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
267%
Monoclonal Antibody
133%
+ 29 programs with unclassified modality

Competitive Landscape

16 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
1 program
1
CelecoxibPhase 4Small Molecule1 trial
Active Trials
NCT00174317Completed250Est. Feb 2005
Sandoz
SandozAustria - Kundl
1 program
1
LumiracoxibPhase 3Small Molecule1 trial
Active Trials
NCT00154219Completed1,200
Prevail Therapeutics
1 program
1
TanezumabPhase 3Monoclonal Antibody1 trial
Active Trials
NCT02709486Completed849Est. Nov 2018
Zimmer Biomet
Zimmer BiometFL - Jacksonville
12 programs
1
articular surface replacement ASR, DePuyPhase 21 trial
A Clinical Investigation of the Balance® Microplasty™ Hip SystemN/A1 trial
Answer® hip stemN/A1 trial
Avenir Complete Femoral StemN/A1 trial
Echo Bi-MetricN/A1 trial
+7 more programs
Active Trials
NCT00699088Completed70Est. Mar 2013
NCT00588861Terminated400Est. May 2010
NCT04731077Active Not Recruiting275Est. Jun 2036
+9 more trials
Stryker
StrykerCA - San Jose
3 programs
CO THAN/A1 trial
MAKO THA 4.0 SystemN/A1 trial
surgical approachN/A1 trial
Active Trials
NCT04095845Completed60Est. Oct 2024
NCT04646096Completed35Est. Oct 2024
NCT03657953Completed157Est. Sep 2015
Anika Therapeutics
Anika TherapeuticsMA - Bedford
2 programs
CingalN/A1 trial
MonoviscN/A1 trial
Active Trials
NCT04640298Completed25Est. Sep 2021
NCT04204083Completed25Est. Mar 2021
Corin
CorinUK - Cirencester
2 programs
Corin Optimised Positioning SystemN/A1 trial
MetaFix Collared StemN/A1 trial
Active Trials
NCT03560063Unknown460Est. May 2022
NCT05121636Active Not Recruiting51Est. Sep 2027
Johnson & Johnson
Johnson & JohnsonNEW BRUNSWICK, NJ
2 programs
Articular Surface ReplacementPHASE_31 trial
Oxycodone CRPHASE_31 trial
Active Trials
NCT00391937Completed150Est. Jan 2013
NCT00361504Completed1,123Est. Jul 2008
Medtronic
MedtronicNJ - Phillipsburg
1 program
AquamantysN/A1 trial
Active Trials
NCT01583465Completed200Est. Sep 2011
Medacta
MedactaSwitzerland - Castel San Pietro
1 program
Femoral Component:Medacta Masterloc Stem and Medacta MPACT cup.N/A1 trial
Active Trials
NCT03168750Completed120Est. Nov 2024
Nordic Pharma
Nordic PharmaFrance - Paris
1 program
Hip SchoolN/A1 trial
Active Trials
NCT01039337Completed118Est. Jun 2011
Organogenesis
OrganogenesisCANTON, MA
1 program
ReNu™ InjectionN/A1 trial
Active Trials
NCT03063099Completed10Est. Jun 2019
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
ShowmotionN/A1 trial
Active Trials
NCT04137835Recruiting60Est. Dec 2025
Embody
EmbodyVA - Norfolk
1 program
The H1 ImplantN/A1 trial
Active Trials
NCT06162195Not Yet Recruiting200Est. Apr 2035
MicroPort
MicroPortChina - Shanghai
1 program
Wright Medical Technology Metal-on-Metal Total Hip SystemN/A1 trial
Active Trials
NCT03450733Completed173Est. Jun 2022
Eppendorf
EppendorfGermany - Hamburg
1 program
everyday activityN/A1 trial
Active Trials
NCT02997891Unknown260Est. May 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
PfizerCelecoxib
Prevail TherapeuticsTanezumab
Johnson & JohnsonOxycodone CR
Johnson & JohnsonArticular Surface Replacement
SandozLumiracoxib
Zimmer Biometarticular surface replacement ASR, DePuy
EmbodyThe H1 Implant
Zimmer BiometTotal Hip Arthroplasty with G7 Freedom Constrained Vivacit-E Liners
Zimmer BiometAvenir Complete Femoral Stem
Colorado TherapeuticsShowmotion
Anika TherapeuticsCingal
Zimmer BiometTotal hip arthoplasty
StrykerMAKO THA 4.0 System
Anika TherapeuticsMonovisc
StrykerCO THA

Showing 15 of 32 trials with date data

Clinical Trials (32)

Total enrollment: 7,866 patients across 32 trials

Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The Hip

Start: Aug 2003Est. completion: Feb 2005250 patients
Phase 4Completed

Study of the Analgesic Efficacy and Safety of Subcutaneous Tanezumab in Subjects With Osteoarthritis of the Hip or Knee.

Start: Mar 2016Est. completion: Nov 2018849 patients
Phase 3Completed

A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain

Start: Nov 2006Est. completion: Jul 20081,123 patients
Phase 3Completed
NCT00391937Johnson & JohnsonArticular Surface Replacement

Efficacy of a New Resurfacing Hip Prosthesis

Start: Oct 2006Est. completion: Jan 2013150 patients
Phase 3Completed

Efficacy and Safety Study of Lumiracoxib in Patients With Primary Hip Osteoarthritis

Start: Nov 20041,200 patients
Phase 3Completed
NCT01113762Zimmer Biometarticular surface replacement ASR, DePuy

Metal-metal Articulations Versus Standard 28 mm Cementless Total Hip Arthroplasty

Start: Feb 2007Est. completion: Nov 201971 patients
Phase 2Unknown
NCT06162195EmbodyThe H1 Implant

The ACTIVE Trial: A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement

Start: Sep 2024Est. completion: Apr 2035200 patients
N/ANot Yet Recruiting
NCT05587244Zimmer BiometTotal Hip Arthroplasty with G7 Freedom Constrained Vivacit-E Liners

G7 Freedom Constrained Vivacit-E Liners

Start: May 2023Est. completion: Dec 2038202 patients
N/AEnrolling By Invitation
NCT04731077Zimmer BiometAvenir Complete Femoral Stem

Avenir Complete Post-Market Clinical Follow-Up Study

Start: Sep 2021Est. completion: Jun 2036275 patients
N/AActive Not Recruiting

Non-invasive Evaluation of Upper and Lower Body Function With Showmotion

Start: Jun 2021Est. completion: Dec 202560 patients
N/ARecruiting

Study of Cingal® for Symptomatic Relief of Osteoarthritis of Hip Joint

Start: Jan 2021Est. completion: Sep 202125 patients
N/ACompleted
NCT04349046Zimmer BiometTotal hip arthoplasty

Exception Cementless Hip Stem

Start: Jan 2021Est. completion: Dec 2025332 patients
N/AActive Not Recruiting
NCT04646096StrykerMAKO THA 4.0 System

Multicenter Study for Robotic Arm-assisted THA 4.0 System: Hip Spine Relationship

Start: Jan 2021Est. completion: Oct 202435 patients
N/ACompleted

MONOVISC for Hip Joint Pain Relief Due to Osteoarthritis

Start: Dec 2019Est. completion: Mar 202125 patients
N/ACompleted

Conventional Total Hip Arthroplasty vs Mako Robotic-arm Assisted Total Hip Arthroplasty

Start: Nov 2018Est. completion: Oct 202460 patients
N/ACompleted
NCT03560063CorinCorin Optimised Positioning System

The Hip Arthroplasty Positioning Improvement Study

Start: May 2018Est. completion: May 2022460 patients
N/AUnknown
NCT03450733MicroPortWright Medical Technology Metal-on-Metal Total Hip System

Wright Medical Technology Metal-on-Metal 522 Post-Market Surveillance Study

Start: Apr 2018Est. completion: Jun 2022173 patients
N/ACompleted
NCT03168750MedactaFemoral Component:Medacta Masterloc Stem and Medacta MPACT cup.

Analysis of a Tapered Porous Coated Stem and a Cementless Hemispherical Acetabular Component

Start: Jul 2017Est. completion: Nov 2024120 patients
N/ACompleted
NCT03063099OrganogenesisReNu™ Injection

ReNu™ Injection to Treat Hip Osteoarthritis Study

Start: Feb 2017Est. completion: Jun 201910 patients
N/ACompleted
NCT05121636CorinMetaFix Collared Stem

Clinical Outcomes Following Total Joint Replacement With Corin Prostheses: Corin MetaFix Collared Stem

Start: Jun 2016Est. completion: Sep 202751 patients
N/AActive Not Recruiting
NCT02997891Eppendorfeveryday activity

Change of Cognitive Performance Through Hip Replacement

Start: Feb 2016Est. completion: May 2018260 patients
N/AUnknown

Evaluation of Stability of Two Uncemented Hip Implants Used for Total Hip Arthroplasty

Start: Jan 2016Est. completion: Dec 202262 patients
N/AUnknown

Evaluation of Cemented and Cementless Fixation of Dual-mobility Hip Prosthesis in Elderly Patients With Osteoarthritis

Start: Oct 2014Est. completion: Mar 201860 patients
N/ACompleted
NCT02851992Zimmer BiometGTS cementless stem

A Prospective Study to Evaluate Long-term Clinical Outcomes of the GTS Cementless Femoral Stem

Start: Sep 2012Est. completion: Sep 2028303 patients
N/AActive Not Recruiting
NCT04079114Zimmer BiometPatients who received the Stafit Acetabular System

Post Market Clinical Follow-Up of the Zimmer Stafit Acetabular System

Start: Apr 2011Est. completion: Jul 2019166 patients
N/ATerminated
NCT04079127Zimmer BiometPatients who met the inclusion/exclusion criteria to receive the Avenir Müller stem.

Avenir Müller Hip Stem Post Market Surveillance Study

Start: Jan 2010Est. completion: Aug 2019150 patients
N/ACompleted

Efficacy of Aquamantys for Reducing Transfusions With Anterior Supine Intermuscular Approach Total Hip Arthroplasty

Start: Oct 2009Est. completion: Sep 2011200 patients
N/ACompleted

Conservative Treatment for Hip Osteoarthritis

Start: Oct 2008Est. completion: Jun 2011118 patients
N/ACompleted
NCT03657953Strykersurgical approach

Outcomes 8 Years After Minimal Invasive THA

Start: Jan 2006Est. completion: Sep 2015157 patients
N/ACompleted
NCT00699088Zimmer BiometA Clinical Investigation of the Balance® Microplasty™ Hip System

A Clinical Investigation of the Balance® Microplasty™ Hip System

Start: Jan 2005Est. completion: Mar 201370 patients
N/ACompleted
NCT00698347Zimmer BiometM2a-Magnum™ Hip System

A Clinical Investigation of the M2a-Magnum™ Hip System

Start: Nov 2004Est. completion: Jan 2015249 patients
N/ATerminated
NCT00588861Zimmer BiometAnswer® hip stem

Total Hip Replacement With the Answer® Hip Stem and Ranawat/Burnstein® Shell Using Simplex® or Palacos® Bone Cement

Start: Sep 2002Est. completion: May 2010400 patients
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 late-stage (Phase 3) programs, potential near-term approvals
1 actively recruiting trials targeting 7,866 patients
16 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.